• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Alvotech Holdings S.A.

    Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    FDA Accepts Alvotech’s BLA Supporting Interchangeability for ATV02, a High Concentration, Citrate-Free Biosimilar Candidate for Humira®
    From Alvotech Holdings S.A.
    Via Business Wire
    Alvotech and Fuji Pharma Expand Partnership for Additional Biosimilar Candidate in Japan
    From Alvotech Holdings S.A.
    Via Business Wire
    Alvotech Enters Exclusive Global Licensing Agreement with BiosanaPharma for Co-Development of a Proposed Biosimilar (AVT23) to Xolair® (Omalizumab)
    From Alvotech Holdings S.A.
    Via Business Wire
    Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Million
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
    From Alvotech Holdings S.A.
    Via Business Wire
    Tickers OACB
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.